Symptom management in geriatric oncology: Practical treatment considerations and current challenges

Current Treatment Options in Oncology

Volumn 9, Issue 2-3, 2008, Pages 204-214

  Barford, Katharine L ^a   D'Olimpio, James T ^a,b  

^a NORTH SHORE UNIVERSITY HOSPITAL   (United States)

^b North Shore Long Island Center for Advanced Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIEMETIC AGENT; APREPITANT; BISACODYL; BUPRENORPHINE; CALCIUM; DEXTROPROPOXYPHENE; DOCUSATE SODIUM; DOLASETRON MESILATE; FENTANYL; FLUOROURACIL; GRANISETRON; HISTAMINE H3 RECEPTOR ANTAGONIST; HYDROMORPHONE; MEDROXYPROGESTERONE; MEGESTROL ACETATE; METHADONE; METHYLPHENIDATE; MODAFINIL; MORPHINE; NARCOTIC ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; ONDANSETRON; OXYCODONE; PALONOSETRON; PARACETAMOL; PETHIDINE; PHOSPHORUS; TACHYKININ RECEPTOR ANTAGONIST; UNINDEXED DRUG;

AGED; AGING; ANOREXIA; ARTICLE; CACHEXIA; CANCER PAIN; CANCER PATIENT; CLINICAL PROTOCOL; CLINICAL TRIAL; COMPETENCE; CONSTIPATION; DEPRESSION; DRUG ABSORPTION; DRUG EFFICACY; DRUG EXCRETION; DRUG METABOLISM; DRUG TOLERABILITY; FATIGUE; GERIATRIC CARE; HUMAN; MALABSORPTION; MALIGNANT NEOPLASTIC DISEASE; MUCOSA INFLAMMATION; NAUSEA; NUTRITIONAL DISORDER; ONCOLOGY; PRACTICE GUIDELINE; SEDATION; SIDE EFFECT; SINGLE DRUG DOSE; SYMPTOM; VOMITING; WEAKNESS; XEROSTOMIA;

AGED; CONSTIPATION; GERIATRICS; HUMANS; MEDICAL ONCOLOGY; NAUSEA; NEOPLASMS; NUTRITIONAL SUPPORT; PAIN; PALLIATIVE CARE; RESEARCH DESIGN; TREATMENT OUTCOME; VOMITING;

EID: 58149088854     PISSN: 15272729     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11864-008-0062-4     Document Type: Article

References (29)

1. Aapro M, Macciocchi A, Gridelli C. Palonosetron improves prevention of chemotherapy-induced nausea and vomiting in elderly patients. J Support Oncol 2005; 3(5):369-374
2. Horiot JC, Aapro M. Treatment implications for radiation-induced nausea and vomiting in specific patient groups. Euro J Cancer 2004; 40(7):979-987. doi: 10.1016/j.ejca.2003.12.023
3. Esbensen BA, Osterlind K, Hallberg IR. Quality of life of elderly persons with cancer: A 6-month follow-up. Scand J Caring Sci 2007; 21(2):178-190. doi: 10.1111/j.1471-6712.2007.00454.x
4. Clark PM. Pharmacologic pain management in the elderly cancer patient. 2001. www.medscape.com/viewarticle/418569
5. Bernabei R, Gambassi G, Lapane K, et al. Management of pain in elderly patients with cancer. JAMA 1998; 279(23):1877-1882. doi: 10.1001/ jama.279.23.1877
6. Delgado-Guay MO, Bruera E. Management of pain in the older person with cancer. Part 1 Oncol 2008, 22(1):56-61; Part 2 Oncol 2008, 22(2):148-152
7. Vigano A, Bruera E, Suarez-Almazor ME. Age, pain intensity, and opioid dose in patients with advanced cancer. Cancer 1998, 83:1244-1250. doi:10.1002/ (SICI)1097-0142(19980915)83:6<1244::AID-CNCR26>3.0.CO;2-4
8. Van den Beuken-van Everdingen MHJ, de Riike JM, et al. Prevalence of pain in patients with cancer: A systematic review of the past 40 years. Annal Oncol 2007; 18(9):1437-1449
9. Constipation in Cancer Patients. http://members.optusnet.com.au/-vchan/ constipation.htm
10. Assessing and Managing Narcotic-Induced Constipation. Cancer Contr J Moffitt Cancer Center. www.medscape.com/viewarticle/417707_8
11. Portenoy RK. Cancer-related fatigue: An immense problem. Oncologist 2000; 5(5):350-352. doi: 10.1634/theoncologist.5-5-350
12. Rao A, Cohen HJ. Symptom management in elderly cancer patient: Fatigue, pain, and depression. J Nat Cancer Inst Monogr 2004; 32:150-157. doi: 10.1093/jncimonographs/lgh031
13. Tumor-Induced Effects on Nutritional Status. National Cancer Institute. www.cancer.gov/cancertopics/pdq/supportivecare/nutrition/ HealthProfessionals/page3
14. Zagaria, MAE. Nutrition in the elderly. US Pharmacist A Jocobson Publication. www.uspharmacist.com
15. Paillaud E, Caillet P, Campillo B, et al. Increased risk of alteration of nutritional status in hospitalized elderly patients with advanced cancer. J Nutrit Health Aging 2006; 10(2):91-95
16. Barber MD, Ross JA, Voss AC, et al. The effect of an oral nutritional supplement enriched with fish oil on weight-loss in patients with pancreatic cancer. Brit J Cancer 1999; 81(1): 80-86. doi: 10.1038/ sj.bjc.6690654
17. Argiles JM, Lopez-Soriano FJ, Busquets S. Novel approaches to the treatment of cachexia. Drug Discov Today 2008; 13(1/2): 73-77. doi: 10.1016/j.drudis.2007.10.008
18. Murphy B. Clinical and economic consequences of mucositis induced by chemotherapy and/or radiation therapy. J Support Oncol 2007; 5(9): 13-21
19. Sonis ST. Oral mucositis in cancer therapy. J Support Oncol 2004; 2(3):3-8
20. Barasch A, Peterson DE. Risk factors for ulcerative oral mucositis in cancer patients: Unanswered questions. Oral Oncol 2003; 39(2): 91-100. doi: 10.1016/S1368-8375(02)00033-7
21. Koestler WJ, Hejna M, Wenzel C, et al. Oral mucositis complicating chemotherapy and/or radiotherapy: Options for prevention and treatment. CA: A Cancer J Clin 2001; 51: 290-315
22. Elting LS, Cooksley C, Chambers M, et al. The burdens of cancer therapy: clinical and economic outcomes of chemotherapy-induced mucositis. Cancer 2003; 98:1531-1539. doi: 10.1002/cncr.11671
23. Guidelines for the treatment of elderly cancer patients. Medscape Today for Web MD. www.medscape.com/viewarticle/465306-9
24. Rubenstein EB, Peterson DE, Schubert M, et al. Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis. Cancer 2004; 100(9): 2026-2046. doi: 10.1002/cncr.20163
25. DiGangi P. Polypharmacy in older adults. Contemp Oral Hygiene Feb 2006. www.contemporaryoralhygieneonline.com/issues/articles/2006-02-03.asp
26. Papas AS, Clark RE, et al. A prospective randomized trial for the prevention of mucositis in patients undergoing bone marrow transplant. Bone Marrow Trans 2003; 31(8): 705-712. doi: 10.1038/sj.bmt.1703870
27. Gridelli C. Same old story? Do we need to modify our supportive care treatment of elderly cancer patients? Focus on antiemetics. Drug Aging 2004; 21(13): 825-832. doi: 10.2165/00002512-200421130-00001
28. Aapro M, Johnson J. Chemotherapy-induced emesis in elderly cancer patients: The role of 5-HT3-receptor antagonists in the first 24 hours. Gerontology 2005; 51(1): 287-296. doi: 10.1159/000086364
29. Aapro M. Optimising antiemetic therapy: What are the problems and how can they be overcome?. Curr Med Res Opin 2005; 21(6): 885-897. doi: 10.1185/030079905X46313